Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:35 PM
Ignite Modification Date:
2025-12-24 @ 2:35 PM
NCT ID:
NCT00030459
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Immunohistochemically or cytologically confirmed malignant mesothelioma
* Epithelial and other histological types
* Symptomatic pleural effusion allowed if treated and controlled by drainage, pleurodesis, or pleurectomy
* Prior surgical resection allowed if stable or progressive disease by 2 CT scan measurements at least 6 weeks apart
PATIENT CHARACTERISTICS:
Age:
* Not specified
Performance status:
* WHO 0-2
Life expectancy:
* Not specified
Hematopoietic:
* WBC greater than 3,000/mm3
* Neutrophil count greater than 1,500/mm3
* Platelet count greater than 100,000/mm3
Hepatic:
* Not specified
Renal:
* Not specified
Other:
* Considered medically fit to receive chemotherapy
* No other disease or prior malignancy that would preclude study
* No clinical evidence of infection
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* Not specified
Chemotherapy:
* No prior chemotherapy for mesothelioma
Endocrine therapy:
* Not specified
Radiotherapy:
* Not specified
Surgery:
* See Disease Characteristics
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00030459
Study Brief:
Protocol Section:
NCT00030459